Allele-specific MMP-3 transcription under in vivo conditions
- 1. Atherosclerosis Research Unit, King Gustav V Research Institute, Department of Medicine, Karolinska Institute, Stockholm (Sweden)
- 2. Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology, Stockholm (Sweden)
Description
A common matrix metalloproteinases-3 (MMP-3) -1612 5A/6A promoter polymorphism is associated with risk for cardiovascular disease, rheumatoid arthritis, and other diseases. Here we used the haplotype chromatin immunoprecipitation method to study allele-specific MMP-3 expression under in vivo conditions in heterozygous THP-1 cells. Pyrosequencing was used to analyse the ratio of 5A-allele to 6A-allele after chromatin immunoprecipitation using an antibody against phosphorylated active RNA polymerase II. There was no allele-specific difference in transcriptional activity during basal conditions, i.e., in unstimulated monocytic THP-1 cells. However, after stimulation of MMP-3 expression by monocyte differentiation or incubation with IL-1β, the haplotype containing the 5A-allele was associated with higher transcriptional activity compared with the 6A-containing haplotype. Electromobility shift assay demonstrated increased binding of nuclear proteins to the 5A-allele after monocyte differentiation. In conclusion, the common MMP-3 5A/6A promoter polymorphism appears to be functional only during specific environmental conditions involving inflammation
Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2006.07.174;
- PII
- S0006-291X(06)01752-9;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 348
- Journal Issue
- 3
- Journal Page Range
- p. 1150-1156
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 38027483
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- ANTIBODIES; CARDIOVASCULAR DISEASES; CHROMATIN; HAZARDS; IN VIVO; INCUBATION; INFLAMMATION; MONOCYTES; PROMOTERS; PROTEINS; RHEUMATIC DISEASES; RNA; STIMULATION; TRANSCRIPTION
- Descriptors DEC
- BIOLOGICAL MATERIALS; BLOOD; BLOOD CELLS; BODY FLUIDS; DISEASES; LEUKOCYTES; MATERIALS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; PATHOLOGICAL CHANGES; SYMPTOMS
Optional Information
- Copyright
- Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.